Trademark applications and grants for Axis Inc. Axis Inc has 2 trademark applications. The latest application filed is for "AXIS FONT"
Patent Application | Date |
---|---|
DIAGNOSTIC AGENT, DIAGNOSTIC METHOD AND THERAPEUTIC AGENT FOR FIBROMYALGIA 20130196980 - 13/877848 Yamano; Yoshihisa ;   et al. | 2013-08-01 |
THERAPEUTIC AGENT FOR FIBROMYALGIA CONTAINING ETANERCEPT 20130108637 - 13/808291 Nishioka; Kusuki | 2013-05-02 |
USE FOR PRODUCTION OF THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR OSTEOARTHRITIS 20130034563 - 13/575632 Nishioka; Kusuki ;   et al. | 2013-02-07 |
INJECTABLE SOLUTION CONTAINING THERAPEUTIC AGENT FOR OSTEOARTHRITIS 20130011416 - 13/575620 Nishioka; Kusuki ;   et al. | 2013-01-10 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF OSTEOARTHRITIS, AND METHOD OF PRODUCTION THEREFOR 20130011407 - 13/575650 Nishioka; Kusuki ;   et al. | 2013-01-10 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "AXIS FONT" 79069885 |
AXIS FONT 2009-05-25 |
![]() "DYTEX" 1713687 74139058 |
DYTEX 1991-02-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.